PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
High Beta
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


MSTR 12.5%NVDA 12.5%SMCI 12.5%ELF 12.5%AVGO 12.5%NVO 12.5%LLY 12.5%ACGL 12.5%EquityEquity
PositionCategory/SectorTarget Weight
ACGL
Arch Capital Group Ltd.
Financial Services
12.50%
AVGO
Broadcom Inc.
Technology
12.50%
ELF
e.l.f. Beauty, Inc.
Consumer Defensive
12.50%
LLY
Eli Lilly and Company
Healthcare
12.50%
MSTR
MicroStrategy Incorporated
Technology
12.50%
NVDA
NVIDIA Corporation
Technology
12.50%
NVO
Novo Nordisk A/S
Healthcare
12.50%
SMCI
Super Micro Computer, Inc.
Technology
12.50%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in High Beta, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


0.00%500.00%1,000.00%1,500.00%2,000.00%NovemberDecember2025FebruaryMarchApril
1,516.56%
142.64%
High Beta
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Sep 22, 2016, corresponding to the inception date of ELF

Returns By Period


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
-10.18%-6.71%-9.92%6.35%13.40%9.65%
High Beta-16.79%-11.00%-19.33%7.16%58.78%N/A
MSTR
MicroStrategy Incorporated
9.52%5.01%46.95%170.16%90.74%33.61%
NVDA
NVIDIA Corporation
-24.42%-14.38%-26.44%33.22%70.28%69.14%
SMCI
Super Micro Computer, Inc.
3.36%-19.42%-33.34%-55.85%71.07%25.82%
ELF
e.l.f. Beauty, Inc.
-58.06%-15.64%-51.34%-66.41%38.14%N/A
AVGO
Broadcom Inc.
-26.02%-10.26%-4.40%43.67%49.90%33.09%
NVO
Novo Nordisk A/S
-31.39%-25.10%-50.02%-51.72%14.53%9.70%
LLY
Eli Lilly and Company
8.99%-0.31%-8.19%16.40%41.59%30.28%
ACGL
Arch Capital Group Ltd.
0.24%0.13%-10.30%4.76%29.64%16.95%
*Annualized

Monthly Returns

The table below presents the monthly returns of High Beta, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-5.38%2.17%-10.96%-3.33%-16.79%
202426.36%34.46%13.83%-9.55%12.13%9.18%-6.92%-6.05%-0.28%2.80%8.96%-3.58%101.69%
202311.17%11.85%12.99%3.80%29.71%10.01%11.17%2.53%-8.06%-3.69%12.41%6.99%152.56%
2022-14.92%1.25%9.56%-18.57%1.58%-12.22%14.76%-8.13%-9.72%13.94%15.33%-5.35%-18.88%
20217.53%7.75%-2.29%4.41%-0.12%16.20%0.25%9.78%-7.65%17.15%13.36%-3.52%78.63%
20202.97%-1.95%-7.81%8.67%12.15%5.95%4.26%12.49%0.98%-5.71%14.92%5.67%62.98%
20195.18%7.63%8.95%1.05%-13.50%10.81%0.51%1.79%2.12%6.28%4.09%5.11%45.12%
20187.78%-5.17%-2.68%-2.28%9.16%-4.21%2.99%5.96%0.39%-15.91%-2.39%-7.07%-15.07%
20170.57%1.29%1.85%-0.50%7.06%1.30%0.93%0.41%0.36%4.39%1.65%-2.88%17.33%
20160.20%-1.38%8.00%4.63%11.67%

Expense Ratio

High Beta has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of High Beta is 8, meaning it’s performing worse than 92% of other portfolios on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of High Beta is 88
Overall Rank
The Sharpe Ratio Rank of High Beta is 88
Sharpe Ratio Rank
The Sortino Ratio Rank of High Beta is 99
Sortino Ratio Rank
The Omega Ratio Rank of High Beta is 99
Omega Ratio Rank
The Calmar Ratio Rank of High Beta is 66
Calmar Ratio Rank
The Martin Ratio Rank of High Beta is 77
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for Portfolio, currently valued at -0.16, compared to the broader market-4.00-2.000.002.00
Portfolio: -0.16
^GSPC: 0.24
The chart of Sortino ratio for Portfolio, currently valued at 0.12, compared to the broader market-6.00-4.00-2.000.002.004.00
Portfolio: 0.12
^GSPC: 0.47
The chart of Omega ratio for Portfolio, currently valued at 1.02, compared to the broader market0.400.600.801.001.201.401.60
Portfolio: 1.02
^GSPC: 1.07
The chart of Calmar ratio for Portfolio, currently valued at -0.25, compared to the broader market0.001.002.003.004.005.006.00
Portfolio: -0.25
^GSPC: 0.24
The chart of Martin ratio for Portfolio, currently valued at -0.58, compared to the broader market0.005.0010.0015.0020.00
Portfolio: -0.58
^GSPC: 1.08

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
MSTR
MicroStrategy Incorporated
1.482.341.273.076.51
NVDA
NVIDIA Corporation
0.270.791.100.441.20
SMCI
Super Micro Computer, Inc.
-0.59-0.570.93-0.80-1.34
ELF
e.l.f. Beauty, Inc.
-0.98-1.700.80-0.89-1.54
AVGO
Broadcom Inc.
0.481.151.150.732.19
NVO
Novo Nordisk A/S
-1.25-1.920.75-0.87-1.81
LLY
Eli Lilly and Company
0.370.791.100.541.11
ACGL
Arch Capital Group Ltd.
0.280.551.070.320.68

The current High Beta Sharpe ratio is -0.13. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.22 to 0.77, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests that it may not be performing as well in terms of risk-adjusted returns compared to many other portfolios. The lower performance could be due to either lower returns, higher volatility, or a combination of both. This might indicate that the portfolio requires some fine-tuning. You can use the Portfolio Optimization tool to find an allocation that maximizes the Sharpe ratio.

Use the chart below to compare the Sharpe ratio of High Beta with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.16
0.24
High Beta
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

High Beta provided a 1.27% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio1.27%1.09%0.44%0.67%0.61%0.85%0.99%1.00%0.85%1.07%0.75%0.97%
MSTR
MicroStrategy Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVDA
NVIDIA Corporation
0.03%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%
SMCI
Super Micro Computer, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ELF
e.l.f. Beauty, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
1.31%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%1.22%
NVO
Novo Nordisk A/S
2.78%1.68%0.99%1.18%1.34%1.86%2.12%2.46%2.13%3.94%1.31%1.96%
LLY
Eli Lilly and Company
0.64%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%
ACGL
Arch Capital Group Ltd.
5.40%5.41%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-27.66%
-14.02%
High Beta
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the High Beta. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the High Beta was 39.47%, occurring on Sep 26, 2022. Recovery took 120 trading sessions.

The current High Beta drawdown is 25.43%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-39.47%Nov 22, 2021212Sep 26, 2022120Mar 20, 2023332
-33.77%Feb 20, 202022Mar 20, 202053Jun 5, 202075
-33.62%Jun 20, 2024201Apr 8, 2025
-29.26%Oct 2, 201858Dec 24, 2018212Oct 28, 2019270
-23.27%Mar 14, 202426Apr 19, 202426May 28, 202452

Volatility

Volatility Chart

The current High Beta volatility is 22.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
22.44%
13.60%
High Beta
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

ACGLLLYNVOELFMSTRSMCIAVGONVDA
ACGL1.000.210.180.240.190.220.210.18
LLY0.211.000.430.160.140.190.230.21
NVO0.180.431.000.170.170.200.240.25
ELF0.240.160.171.000.270.290.300.29
MSTR0.190.140.170.271.000.310.350.40
SMCI0.220.190.200.290.311.000.390.41
AVGO0.210.230.240.300.350.391.000.63
NVDA0.180.210.250.290.400.410.631.00
The correlation results are calculated based on daily price changes starting from Sep 23, 2016
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab